Actemra Tocilizumab Injection 400 MG
Form: Injection
Marketed by: CIPLA LTD (CANCER CARE)
MRP: ₹44559.00
Actemra 400mg by Cipla (tocilizumab 400 mg, 1 pack) is an interleukin-6 (IL-6) receptor-blocking monoclonal antibody listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by rheumatologists and oncologists for rheumatoid arthritis, juvenile idiopathic arthritis and cytokine release syndrome, including the severe reaction that can follow CAR-T cell cancer therapy. Schedule H: dispense only against a valid prescription. Counselling point: screen for TB and hepatitis B first; given as an IV infusion under supervision. Cold-chain item: store at 2-8°C, do not freeze.
Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.